103 related articles for article (PubMed ID: 1399954)
41. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
Nimmo GR; Bull JZ
J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial activity of imipenem and SCH34343 against Legionella species.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):307-9. PubMed ID: 3472705
[TBL] [Abstract][Full Text] [Related]
43. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
Bouanchaud DH
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of azithromycin against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1991 Jan; 35(1):180-1. PubMed ID: 1849708
[TBL] [Abstract][Full Text] [Related]
46. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Inoue M; Okamoto R; Okubo T; Inoue K; Mitsuhashi S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():45-51. PubMed ID: 1399950
[TBL] [Abstract][Full Text] [Related]
47. Activity of macrolides against organisms responsible for respiratory infection with emphasis on Mycoplasma and Legionella.
Hara K; Suyama N; Yamaguchi K; Kohno S; Saito A
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():75-80. PubMed ID: 3429389
[TBL] [Abstract][Full Text] [Related]
48. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.
Traub WH; Spohr M
Chemotherapy; 1984; 30(3):182-7. PubMed ID: 6734305
[TBL] [Abstract][Full Text] [Related]
49. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
L'Hériteau F; Entenza JM; Lacassin F; Leport C; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1995 Jul; 39(7):1425-9. PubMed ID: 7492079
[TBL] [Abstract][Full Text] [Related]
50. The antibacterial activity of compounds isolated from oakmoss against Legionella pneumophila and other Legionella spp.
Nomura H; Isshiki Y; Sakuda K; Sakuma K; Kondo S
Biol Pharm Bull; 2012; 35(9):1560-7. PubMed ID: 22975509
[TBL] [Abstract][Full Text] [Related]
51. Determination of binding parameters of macrolides, lincosamides, and streptogramins to Legionella pneumophila.
Fournet MP; Zini R; Deforges L; Duval J; Tillement JP
J Pharm Sci; 1987 Feb; 76(2):153-6. PubMed ID: 3572754
[TBL] [Abstract][Full Text] [Related]
52. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.
Pasculle AW; Dowling JN; Weyant RS; Sniffen JM; Cordes LG; Gorman GM; Feeley JC
Antimicrob Agents Chemother; 1981 Dec; 20(6):793-9. PubMed ID: 7325645
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
54. RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Nichterlein T; Kretschmar M; Hof H
J Chemother; 1996 Apr; 8(2):107-12. PubMed ID: 8708741
[TBL] [Abstract][Full Text] [Related]
55. Fleroxacin (Ro 23-6240): activity in vitro against 355 enteropathogenic and non-fermentative gram-negative bacilli and Legionella pneumophila.
Hohl P; von Graevenitz A; Zollinger-Iten J
J Antimicrob Chemother; 1987 Sep; 20(3):373-8. PubMed ID: 3119553
[TBL] [Abstract][Full Text] [Related]
56. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
[TBL] [Abstract][Full Text] [Related]
57. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.
Saito A; Sawatari K; Fukuda Y; Nagasawa M; Koga H; Tomonaga A; Nakazato H; Fujita K; Shigeno Y; Suzuyama Y
Antimicrob Agents Chemother; 1985 Jul; 28(1):15-20. PubMed ID: 3862361
[TBL] [Abstract][Full Text] [Related]
58. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
[TBL] [Abstract][Full Text] [Related]
60. Antibiotic susceptibility of Legionella strains isolated from public water sources in Macau and Guangzhou.
Xiong L; Yan H; Shi L; Mo Z
J Water Health; 2016 Dec; 14(6):1041-1046. PubMed ID: 27959883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
